{"id":"https://openalex.org/W2145306293","doi":"https://doi.org/10.1136/ard.2008.094524","title":"Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate","display_name":"Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate","alternate_titles":[],"publication_year":2008,"publication_date":"2008-06-06","ids":{"openalex":"https://openalex.org/W2145306293","doi":"https://doi.org/10.1136/ard.2008.094524","mag":"2145306293","pmid":"https://pubmed.ncbi.nlm.nih.gov/18535115","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2566536"},"language":"en","primary_location":{"id":"doi:10.1136/ard.2008.094524","doi":"https://doi.org/10.1136/ard.2008.094524","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ard.2008.094524","pdf_url":"https://ard.bmj.com/content/annrheumdis/67/10/1444.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145306293"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ard.bmj.com/content/annrheumdis/67/10/1444.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107413697","display_name":"Arthur Kavanaugh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"A Kavanaugh","raw_affiliation_strings":["Center for Innovative Therapy, Division of Rheumatology, Allergy, and Immunology, UCSD, San Diego, California, USA. akavanaugh@ucsd.edu","Center for Innovative Therapy, Division of Rheumatology, Allergy, and Immunology, 9500 Gilman Drive, Mail Code 0943, La Jolla, CA 92093, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Innovative Therapy, Division of Rheumatology, Allergy, and Immunology, UCSD, San Diego, California, USA. akavanaugh@ucsd.edu","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Center for Innovative Therapy, Division of Rheumatology, Allergy, and Immunology, 9500 Gilman Drive, Mail Code 0943, La Jolla, CA 92093, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071491614","display_name":"Lars Klareskog","orcid":"https://orcid.org/0000-0001-9601-6186","observed_orcids":["https://orcid.org/0000-0001-9601-6186"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"L Klareskog","raw_affiliation_strings":["Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104506506","display_name":"D\u00e9sir\u00e9e M F M van der Heijde","orcid":"https://orcid.org/0000-0002-5781-158X","observed_orcids":["https://orcid.org/0000-0002-5781-158X"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"D van der Heijde","raw_affiliation_strings":["Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088222419","display_name":"J Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Li","raw_affiliation_strings":["Amgen Inc, Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111920901","display_name":"B Freundlich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Freundlich","raw_affiliation_strings":["Wyeth Pharmaceuticals, Collegeville, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Pharmaceuticals, Collegeville, Pennsylvania, USA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017122892","display_name":"M. Hooper","orcid":"https://orcid.org/0009-0009-4079-1058","observed_orcids":["https://orcid.org/0009-0009-4079-1058"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Hooper","raw_affiliation_strings":["Amgen Inc, Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5107413697"],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":{"value":4870,"currency":"USD","value_usd":4870},"fwci":2.2125,"has_fulltext":true,"cited_by_count":43,"citation_normalized_percentile":{"value":0.86158342,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"67","issue":"10","first_page":"1444","last_page":"1447"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":1.0},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":1.0},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9850000143051147},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.9049999713897705},{"id":"https://openalex.org/keywords/delayed-treatment-response","display_name":"delayed treatment response","score":0.9010000228881836},{"id":"https://openalex.org/keywords/acr-response-criteria","display_name":"ACR response criteria","score":0.7929999828338623},{"id":"https://openalex.org/keywords/sustained-response","display_name":"sustained response","score":0.6119999885559082},{"id":"https://openalex.org/keywords/radiographic-progression","display_name":"radiographic progression","score":0.9860000014305115},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.9855160713195801},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9759474992752075},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.8843479156494141},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.8700023889541626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7045660614967346},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.6867133378982544},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.45621055364608765},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41031455993652344},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.38283973932266235},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3530900478363037}],"mesh":[{"descriptor_ui":"D000068800","descriptor_name":"Etanercept","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011859","descriptor_name":"Radiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1136/ard.2008.094524","doi":"https://doi.org/10.1136/ard.2008.094524","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ard.2008.094524","pdf_url":"https://ard.bmj.com/content/annrheumdis/67/10/1444.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},{"id":"pmid:18535115","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18535115","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the rheumatic diseases","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2566536","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2566536/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Rheum Dis","raw_type":"Text"},{"id":"pmh:oai:open-archive.highwire.org:annrheumdis:ard.2008.094524v1","doi":null,"is_oa":false,"landing_page_url":"http://ard.bmj.com/cgi/content/short/ard.2008.094524v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.598.7015","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.598.7015","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://ard.bmj.com/content/67/10/1444.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.889.5361","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.889.5361","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://ard.bmj.com/content/early/2008/06/05/ard.2008.094524.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1136/ard.2008.094524","doi":"https://doi.org/10.1136/ard.2008.094524","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ard.2008.094524","pdf_url":"https://ard.bmj.com/content/annrheumdis/67/10/1444.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2145306293.pdf","grobid_xml":"https://content.openalex.org/works/W2145306293.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1499124767","https://openalex.org/W1984069584","https://openalex.org/W2024644107","https://openalex.org/W2053320649","https://openalex.org/W2060943696","https://openalex.org/W2077384389","https://openalex.org/W2100736304","https://openalex.org/W2116843833","https://openalex.org/W2118704147","https://openalex.org/W2124670599","https://openalex.org/W2125935509","https://openalex.org/W2132646805","https://openalex.org/W2163624896","https://openalex.org/W2183378329","https://openalex.org/W2314052274","https://openalex.org/W2340084730"],"related_works":["https://openalex.org/W7101008761","https://openalex.org/W2056133176","https://openalex.org/W2314713852","https://openalex.org/W3100354371","https://openalex.org/W3177783850","https://openalex.org/W2994706030","https://openalex.org/W2142399236","https://openalex.org/W1980690811","https://openalex.org/W2286943473"],"abstract_inverted_index":{"BACKGROUND:":[0],"Whereas":[1],"many":[2],"patients":[3,15],"respond":[4],"quickly":[5],"to":[6,61,77,138,168],"treatment":[7],"with":[8,35,45,152,170],"tumour":[9],"necrosis":[10],"factor":[11],"(TNF)":[12],"inhibitors,":[13],"some":[14,203],"may":[16,199],"experience":[17],"significant":[18,161],"but":[19],"delayed":[20,146],"responses.":[21],"OBJECTIVE:":[22],"To":[23],"evaluate":[24],"the":[25,39,94,124,130,142],"clinical":[26,147,181,187],"response":[27,51,67,76,137,148,182,188],"between":[28],"12":[29,112,177,197],"and":[30,43,97,106,165],"24":[31,55,126],"weeks":[32,56,79,198],"in":[33,57,93,100,116,129,202],"subjects":[34,72,90],"rheumatoid":[36,204],"arthritis":[37,205],"from":[38,88],"Trial":[40],"of":[41,64,71,123,163],"Etanercept":[42],"Methotrexate":[44],"Radiographic":[46],"Patient":[47],"Outcomes.":[48],"METHODS:":[49],"Clinical":[50],"was":[52,80,149],"assessed":[53],"at":[54,110,118,156,175,189,196],"12-week":[58],"non-responders,":[59],"according":[60],"American":[62],"College":[63],"Rheumatology":[65],"(ACR)":[66],"criteria.":[68],"The":[69],"proportion":[70,162],"who":[73],"successfully":[74],"maintained":[75],"52":[78,139],"analysed,":[81],"as":[82],"were":[83,91],"radiographic":[84,154],"outcomes.":[85],"RESULTS:":[86],"Data":[87],"682":[89],"included":[92],"analysis.":[95],"Non":[96],"partial":[98,166],"responders":[99,128,167],"all":[101],"three":[102],"groups":[103],"(etanercept,":[104],"methotrexate":[105,133,173],"etanercept":[107,131,143,169],"plus":[108,132],"methotrexate)":[109],"week":[111,119,125,157,176,190],"showed":[113],"an":[114],"improvement":[115],"responses":[117],"24.":[120,191],"Over":[121],"80%":[122],"ACR20/50/70":[127],"arm":[134],"sustained":[135],"their":[136,185],"weeks.":[140],"In":[141],"arms,":[144],"a":[145,179],"not":[150],"associated":[151],"increased":[153],"progression":[155],"52.":[158],"CONCLUSION:":[159],"A":[160],"non":[164],"or":[171,183],"without":[172],"therapy":[174,195],"achieved":[178],"good":[180],"improved":[184],"overall":[186],"Discontinuing":[192],"TNF":[193],"inhibitor":[194],"be":[200],"premature":[201],"patients.":[206]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145306293","counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
